Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug131 | 44473425 | Florilglutamic acid F-18 | NCT03358706 | C8H14FNO4 | 206.20 | NULL | NULL | Details |
| Drug132 | 44475014 | Hydroxocobalamin | NCT04259060 | C62H89CoN13O15P | 1346.40 | approved | YES | Details |
| Drug133 | 44603362 | GSK2586184 | NCT02000453 | C22H23N5O2 | 389.40 | NULL | NULL | Details |
| Drug134 | 44623998 | Etrasimod | NCT03139032, NCT06294925, NCT03950232, NCT05061446, NCT04607837, NCT05287126, NCT03996369, NCT06398626, NCT03945188, NCT02447302, NCT04706793, NCT02536404, NCT06025227, NCT04176588 | C26H26F3NO3 | 457.50 | NULL | YES | Details |
| Drug135 | 45138527 | VB-201 | NCT03581149 | C29H60NO8P | 581.80 | NULL | NULL | Details |
| Drug136 | 49831257 | Filgotinib | NCT03201445, NCT06865417, NCT02914522, NCT02914535, NCT05479058, NCT05817942, NCT03046056, NCT03077412, NCT02914561, NCT02048618 | C21H23N5O3S | 425.50 | NULL | NO | Details |
| Drug137 | 49846599 | ABX464 | NCT04023396, NCT05507203, NCT05177835, NCT05507216, NCT03093259, NCT03368118, NCT05535946, NCT03760003 | C16H10ClF3N2O | 338.71 | NULL | NULL | Details |
| Drug138 | 52912218 | GB004 | NCT03860896, NCT04556383 | C22H28ClN3O4 | 433.90 | NULL | NULL | Details |
| Drug139 | 52938427 | Ozanimod | NCT05702879, NCT05382715, NCT05369832, NCT03915769, NCT05076175, NCT06126835, NCT06073873, NCT01647516, NCT05644665, NCT05809583, NCT06188637, NCT02435992, NCT02531126, NCT02531113 | C23H24N4O3 | 404.50 | NULL | YES | Details |
| Drug140 | 53380437 | Itacitinib | NCT03627052 | C26H23F4N9O | 553.50 | NULL | NULL | Details |